Subscribe

Integra LifeSciences Holdings Corporation (IART)

USD18.58 -0.21 (-1.12%)
US NASDAQ Healthcare Medical - Devices
Address 1100 Campus Road 8540
Princeton, NJ, US
CEO Mojdeh Poul
IPO 1995-08-16
CIK 917520 ISIN US4579852082

Explore sections of this company profile

Description

Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.

News Sentiment (7d)
75 Positive

3 articles

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD18.58 -0.21 (-1.12%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
1.25
Float Shares
58.83M
Free Float %
75.5%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-1.43% -2.96% +39.09% +27.38% +13.90% +10.87% +0.73% -71.93% -80.31% -61.42% +197.73%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (26 ratings, all time) Buy
Price Targets & DCF
Current price
18.58
Low 12.00 -35.4%
Consensus 12.00 -35.4%
Median 12.00 -35.4%
High 12.00 -35.4%
DCF (Unlevered) 41.89 +125.5%
DCF (Levered) 55.81 +200.4%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 22% Bullish
Rating 2026-05 Change
Strong Buy 1 0
Buy 1 -1
Hold 5 0
Sell 1 0
Strong Sell 1 -1
Price Target Summary
Period # Analysts Avg Target
Last Month 1
12.00
-35.4%
Last Quarter 1
12.00
-35.4%
Last Year 2
13.50
-27.3%
All Time 15
38.60
+107.8%
Quality scores
Altman Z-Score
0.76
Distress
Piotroski F-Score
5 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Devices: +11.2%
    +1.5% Q1'26: +2.4% (vs Q1'25)
  • EPS growth Medical - Devices: +28.5%
    -7,361.2% Q1'26: +81.8% (vs Q1'25)
  • FCF margin FCF growth · Medical - Devices: +30.9%
    -29.4% Q1'26: -1.3% (vs Q1'25)
  • EBIT margin Medical - Devices: +6.2%
    -29.2% Q1'26: +10.2% (vs Q1'25)
  • ROIC Medical - Devices: +3.3%
    -17.0% Q1'26: +5.7% (vs Q1'25)
  • Share dilution Medical - Devices: 0.0%
    -0.3% Q1'26: +0.6% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×
    -6.23× Q1'26: 6.49× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.08) × ERP
WACC = 34% × Ke + 66% × Kd (4.2%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 43.38 Current price: 18.58
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2006
actual
Dec 2010
actual
Dec 2011
actual
Dec 2012
actual
Dec 2013
actual
Dec 2014
actual
Dec 2015
actual
Dec 2016
actual
Dec 2017
actual
Dec 2018
actual
Dec 2019
actual
Dec 2020
actual
Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
6 Rev. Ana.
4 EPS Ana.
Dec 2027
6 Rev. Ana.
5 EPS Ana.
Dec 2028
6 Rev. Ana.
2 EPS Ana.
Revenue
419.30M
est: 395.16M (+6.1%)
732.07M
est: 665.18M (+10.1%)
780.08M
est: 746.68M (+4.5%)
830.87M
est: 756.73M (+9.8%)
836.21M
est: 844.89M (-1.0%)
928.31M
est: 780.25M (+19.0%)
882.73M
est: 882.57M (+0.0%)
992.08M
est: 994.12M (-0.2%)
1.19B
est: 1.17B (+1.2%)
1.47B
est: 1.47B (+0.1%)
1.52B
est: 1.52B (-0.2%)
1.37B
est: 1.37B (0.0%)
1.54B
est: 1.54B (+0.1%)
1.56B
est: 1.56B (0.0%)
1.54B
est: 1.57B (-1.6%)
1.61B
est: 1.61B (-0.2%)
1.64B
est: 1.63B (+0.3%)
1.68B
1.67B – 1.69B
+2.8% YoY
1.73B
1.72B – 1.74B
+3.3% YoY
1.79B
1.79B – 1.79B
+3.2% YoY
EBITDA
58.74M
est: 65.61M (-10.5%)
139.64M
est: 125.45M (+11.3%)
106.31M
est: 102.15M (+4.1%)
116.46M
est: 113.68M (+2.4%)
40.07M
est: 42.33M (-5.3%)
172.24M
est: 122.37M (+40.8%)
195.59M
est: 116.39M (+68.1%)
231.73M
est: 183.45M (+26.3%)
135.23M
est: 130.31M (+3.8%)
241.04M
est: 219.52M (+9.8%)
223.52M
est: 209.47M (+6.7%)
267.93M
est: 256.60M (+4.4%)
366.33M
est: 300.57M (+21.9%)
384.60M
est: 322.21M (+19.4%)
255.96M
est: 178.89M (+43.1%)
193.29M
est: 184.22M (+4.9%)
-326.20M
est: 186.19M (-275.2%)
191.43M
190.29M – 192.58M
+2.8% YoY
197.79M
196.65M – 198.93M
+3.3% YoY
204.16M
204.16M – 204.16M
+3.2% YoY
EBIT
58.74M
est: 55.28M (+6.3%)
100.47M
est: 88.65M (+13.3%)
56.13M
est: 53.23M (+5.5%)
74.27M
est: 66.10M (+12.4%)
-6.94M
est: -3.24M (-114.3%)
67.53M
est: 63.40M (+6.5%)
84.21M
est: 59.22M (+42.2%)
116.21M
est: 112.13M (+3.6%)
46.33M
est: 43.96M (+5.4%)
125.34M
est: 104.65M (+19.8%)
114.06M
est: 87.18M (+30.8%)
148.95M
est: 129.39M (+15.1%)
242.66M
est: 169.80M (+42.9%)
263.49M
est: 214.49M (+22.8%)
132.45M
est: 48.04M (+175.7%)
52.40M
est: 49.47M (+5.9%)
-477.25M
est: 50.00M (-1,054.6%)
51.40M
51.10M – 51.71M
+2.8% YoY
53.11M
52.80M – 53.42M
+3.3% YoY
54.82M
54.82M – 54.82M
+3.2% YoY
Net Income
29.41M
est: 27.51M (+6.9%)
65.67M
est: 59.02M (+11.3%)
27.99M
est: 27.10M (+3.3%)
41.20M
est: 37.38M (+10.2%)
-16.98M
est: -16.77M (-1.3%)
34.00M
est: 32.75M (+3.8%)
-3.52M
est: -5.13M (+31.4%)
74.56M
est: 70.75M (+5.4%)
64.74M
est: 58.37M (+10.9%)
60.80M
est: 57.57M (+5.6%)
50.20M
est: 45.94M (+9.3%)
133.89M
est: 108.10M (+23.9%)
169.08M
est: 144.29M (+17.2%)
180.55M
est: 161.85M (+11.6%)
67.74M
est: 23.20M (+192.0%)
-6.94M
est: 188.16M (-103.7%)
-516.47M
est: 168.96M (-405.7%)
186.56M
182.27M – 190.84M
+10.4% YoY
201.52M
195.27M – 207.77M
+8.0% YoY
219.74M
182.22M – 257.26M
+9.0% YoY
SGA
157.71M
est: 148.38M (+6.3%)
305.06M
est: 274.18M (+11.3%)
358.13M
est: 341.16M (+5.0%)
373.11M
est: 334.91M (+11.4%)
394.25M
est: 395.97M (-0.4%)
445.97M
est: 434.53M (+2.6%)
415.76M
est: 422.76M (-1.7%)
455.63M
est: 441.68M (+3.2%)
624.10M
est: 599.32M (+4.1%)
690.75M
est: 652.13M (+5.9%)
687.60M
est: 648.00M (+6.1%)
594.53M
est: 579.92M (+2.5%)
637.45M
est: 543.07M (+17.4%)
616.32M
est: 619.02M (-0.4%)
656.64M
est: 660.43M (-0.6%)
716.98M
est: 680.12M (+5.4%)
699.70M
est: 687.37M (+1.8%)
706.73M
702.50M – 710.96M
+2.8% YoY
730.21M
725.99M – 734.43M
+3.3% YoY
753.74M
753.74M – 753.74M
+3.2% YoY
EPS
0.50
est: 0.64 (-21.9%)
1.11
est: 1.17 (-5.1%)
0.52
est: 1.31 (-60.3%)
0.74
est: 1.27 (-41.7%)
-0.30
est: 1.25 (-124.0%)
0.52
est: 1.75 (-70.3%)
-0.05
est: 1.54 (-103.1%)
1.00
est: 1.76 (-43.0%)
0.83
est: 1.86 (-55.3%)
0.73
est: 2.39 (-69.5%)
0.59
est: 2.74 (-78.5%)
1.58
est: 2.35 (-32.9%)
2.00
est: 3.18 (-37.0%)
2.18
est: 3.31 (-34.2%)
0.87
est: 0.30 (+187.6%)
-0.09
est: 2.45 (-103.7%)
-6.73
est: 2.20 (-405.7%)
2.44
2.37 – 2.49
+10.6% YoY
2.62
2.54 – 2.71
+7.4% YoY
2.86
2.37 – 3.35
+9.5% YoY
Recent Grade Changes (3M)
Date Firm Previous New Grade Action
2026-05-06 Citigroup Sell Sell Maintain
2026-04-15 Truist Securities Hold Hold Maintain
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-11 C+ 2/5 4/5 1/5 1/5 1/5 1/5 5/5
2026-05-08 C+ 2/5 4/5 1/5 1/5 1/5 1/5 5/5
2026-05-07 B- 2/5 4/5 1/5 1/5 2/5 1/5 5/5
2026-05-06 B- 2/5 4/5 1/5 1/5 2/5 1/5 5/5
2026-05-05 B- 2/5 4/5 1/5 1/5 2/5 1/5 5/5
2026-05-04 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-05-01 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-30 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-29 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-28 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-27 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-24 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-23 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-22 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-21 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-20 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-17 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-16 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-15 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-21.60M
OE per share TTM
-0.28
Owner's Yield
-2.04%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
30.5%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
44
Total invested
17.88M
Insider transactions (90d)
0
Beneficial owners (>5%)
14
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 Richard E. Caruso, Ph.D. 11.05M 12.87% 163.7K 10.89M 163.7K IN 2020-02-11
2 Capital Research Global Investors ** 9.12M 10.60% 9.12M 9.12M IA 2020-02-14
3 Provco Leasing Corporation 8.74M 10.32% 8.74M 8.74M CO 2022-02-14
4 Tru St Partnership LP 8.74M 10.32% 8.74M 8.74M PN 2022-02-14
5 (1) BlackRock, Inc. 6.76M 8.00% 6.55M 6.76M HC Delaware 2022-02-01
6 The Vanguard Group - 23-1945930 6.66M 7.86% 34.1K 6.56M 98.1K IA Pennsylvania 2022-02-10
7 Morgan Stanley 5.68M 6.80% 5.34M 5.66M HC, CO 2023-02-09
8 Wellington Group Holdings LLP 5.35M 6.41% 4.75M HC Massachusetts 2022-10-11
9 Wellington Investment Advisors Holdings LLP 5.35M 6.41% 4.75M HC Massachusetts 2022-10-11
10 Wellington Management Group LLP 5.35M 6.41% 4.75M HC Massachusetts 2022-10-11
11 Wellington Management Company LLP 5.08M 6.08% 4.62M IA Massachusetts 2022-10-11
12 Fuller & Thaler Asset Management, Inc. 3.97M 5.11% 3.91M 3.97M IA California 2024-11-12
13 EIN #00-0000000 3.75M 4.40% 3.75M 3.75M IA, HC 2022-02-10
14 95-1411037 13.00 5.50% 4.30M 4.30M IA Delaware 2024-02-09

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
44
-162 vs prev Q
New positions
3
Closed positions
165
Increased
12
Reduced
21
Put/Call ratio
0.00
Calls held
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 BLACKROCK, INC. 10.35M +118.5K (+1.2%) 128.52M -18.1M (-12.3%) 13.48% +0.104 pp 0.00% 0.000 pp USD18.20 -31.8% 6 qtrs
2 RUBRIC CAPITAL MANAGEMENT LP 7.75M +100.0K (+1.3%) 96.30M -13.4M (-12.2%) 10.10% +0.093 pp 1.15% -0.086 pp USD18.24 -31.9% 6 qtrs
3 VANGUARD GROUP INC 7.21M -168.5K (-2.3%) 89.56M -16.2M (-15.3%) 9.39% -0.256 pp 0.00% 0.000 pp USD35.88 -65.4% 84 qtrs
4 MORGAN STANLEY 3.85M +24.4K (+0.6%) 47.81M -7.0M (-12.8%) 5.01% +0.013 pp 0.00% -0.001 pp USD52.71 -76.4% 51 qtrs
5 FULLER & THALER ASSET MANAGEMENT, INC. 3.64M -278.1K (-7.1%) 45.16M -10.9M (-19.5%) 4.74% -0.382 pp 0.15% -0.038 pp USD26.14 -52.5% 27 qtrs
6 INVESCO LTD. 3.52M +31.9K (+0.9%) 43.75M -6.3M (-12.5%) 4.59% +0.024 pp 0.01% -0.001 pp USD26.87 -53.8% 57 qtrs
7 DIMENSIONAL FUND ADVISORS LP 3.09M -96.9K (-3.0%) 38.35M -7.3M (-16.0%) 4.02% -0.142 pp 0.01% -0.002 pp USD31.32 -60.3% 51 qtrs
8 STATE STREET CORP 2.81M +21.7K (+0.8%) 34.93M -5.1M (-12.7%) 3.66% +0.015 pp 0.00% 0.000 pp USD39.03 -68.2% 51 qtrs
9 PARADIGM CAPITAL MANAGEMENT INC/NY 2.66M +135.2K (+5.3%) 33.10M -3.2M (-8.7%) 3.47% +0.164 pp 1.39% -0.178 pp USD17.09 -27.3% 6 qtrs
10 NEUBERGER BERMAN GROUP LLC 2.08M +542.0K (+35.3%) 25.82M +3.9M (+17.6%) 2.71% +0.699 pp 0.02% +0.003 pp USD22.25 -44.2% 13 qtrs
11 GEODE CAPITAL MANAGEMENT, LLC 1.68M +135.7K (+8.8%) 20.92M -1.3M (-5.7%) 2.19% +0.169 pp 0.00% 0.000 pp USD36.31 -65.8% 78 qtrs
12 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.56M +169.9K (+12.2%) 19.37M -544.7K (-2.7%) 2.03% +0.215 pp 0.00% 0.000 pp USD31.22 -60.2% 99 qtrs
13 GOLDMAN SACHS GROUP INC 1.44M -96.6K (-6.3%) 17.83M -4.1M (-18.8%) 1.87% -0.133 pp 0.00% -0.001 pp USD32.56 -61.9% 73 qtrs
14 WELLINGTON MANAGEMENT GROUP LLP 1.35M +32.2K (+2.4%) 16.81M -2.1M (-11.2%) 1.76% +0.035 pp 0.00% 0.000 pp USD43.78 -71.6% 37 qtrs
15 J. GOLDMAN & CO LP 1.24M +293.0K (+30.8%) 15.45M +1.8M (+13.4%) 1.62% +0.377 pp 0.41% +0.064 pp USD13.30 -6.6% 6 qtrs
16 SYSTEMATIC FINANCIAL MANAGEMENT LP 1.11M +48.1K (+4.5%) 13.77M -1.4M (-9.4%) 1.44% +0.057 pp 0.32% -0.045 pp USD22.74 -45.4% 8 qtrs
17 INVENOMIC CAPITAL MANAGEMENT LP 1.06M +463.7K (+78.3%) 13.11M +4.6M (+54.5%) 1.38% +0.601 pp 0.61% +0.200 pp USD12.41 +0.1% 3 qtrs
18 QUANTINNO CAPITAL MANAGEMENT LP 842.1K +601.7K (+250.4%) 10.46M +7.0M (+203.7%) 1.10% +0.783 pp 0.02% +0.012 pp USD13.69 -9.3% 12 qtrs
19 BANK OF AMERICA CORP /DE/ 825.1K +201.0K (+32.2%) 10.25M +1.3M (+14.6%) 1.08% +0.259 pp 0.00% +0.000 pp USD28.56 -56.5% 52 qtrs
20 GLENMEDE TRUST CO NA 772.9K +772.9K (+100.0%) 9.60M +9.6M (+100.0%) 1.01% +1.007 pp 0.05% +0.046 pp USD12.42 +0.0% 1 qtrs NEW
21 NORTHERN TRUST CORP 750.0K -64.4K (-7.9%) 9.31M -2.4M (-20.2%) 0.98% -0.088 pp 0.00% 0.000 pp USD26.21 -52.6% 51 qtrs
22 ALLIANZ ASSET MANAGEMENT GMBH 650.6K +216.9K (+50.0%) 8.08M +1.9M (+30.0%) 0.85% +0.281 pp 0.01% +0.001 pp USD15.28 -18.7% 5 qtrs
23 ASSENAGON ASSET MANAGEMENT S.A. 526.3K +72.0K (+15.8%) 6.54M +25.8K (+0.4%) 0.69% +0.092 pp 0.01% +0.000 pp USD20.92 -40.6% 10 qtrs
24 JPMORGAN CHASE & CO 521.1K -30.6K (-5.5%) 6.47M -1.4M (-18.1%) 0.68% -0.043 pp 0.00% 0.000 pp USD23.08 -46.2% 45 qtrs
25 BANK OF NEW YORK MELLON CORP 484.4K +90.5K (+23.0%) 6.02M +371.1K (+6.6%) 0.63% +0.116 pp 0.00% +0.000 pp USD33.49 -62.9% 66 qtrs
26 D. E. SHAW & CO., INC. 469.6K -155.6K (-24.9%) 5.83M -3.1M (-34.9%) 0.61% -0.206 pp 0.00% -0.002 pp USD25.81 -51.9% 49 qtrs
27 PRINCIPAL FINANCIAL GROUP INC 437.9K +35.7K (+8.9%) 5.44M -324.4K (-5.6%) 0.57% +0.045 pp 0.00% 0.000 pp USD29.30 -57.6% 81 qtrs
28 CANADA PENSION PLAN INVESTMENT BOARD 434.4K +2.1K (+0.5%) 5.40M -799.6K (-12.9%) 0.57% +0.001 pp 0.00% -0.001 pp USD13.18 -5.8% 7 qtrs
29 VOLORIDGE INVESTMENT MANAGEMENT, LLC 433.4K -60.6K (-12.3%) 5.38M -1.7M (-24.0%) 0.56% -0.081 pp 0.02% -0.005 pp USD28.29 -56.1% 16 qtrs
30 ACCESS INVESTMENT MANAGEMENT LLC 372.5K +— (+0.0%) 5.34M +— (+0.0%) 0.49% -0.002 pp 1.43% +0.000 pp USD12.27 +1.2% 3 qtrs
31 KOTLER KEVIN 427.4K +427.4K (+100.0%) 5.31M +5.3M (+100.0%) 0.56% +0.557 pp 1.24% +1.242 pp USD12.42 +0.0% 1 qtrs NEW
32 DEUTSCHE BANK AG\ 424.8K +66.4K (+18.5%) 5.28M +140.2K (+2.7%) 0.55% +0.085 pp 0.00% +0.000 pp USD15.53 -20.0% 50 qtrs
33 UBS GROUP AG 409.0K +277.7K (+211.7%) 5.08M +3.2M (+170.1%) 0.53% +0.361 pp 0.00% +0.001 pp USD16.03 -22.5% 45 qtrs
34 SG AMERICAS SECURITIES, LLC 380.2K +380.2K (+100.0%) 4.72M +4.7M (+100.0%) 0.50% +0.495 pp 0.01% +0.006 pp USD12.42 +0.0% 3 qtrs
35 LEGAL & GENERAL GROUP PLC 368.9K +126.2K (+52.0%) 4.58M +1.1M (+31.7%) 0.48% +0.163 pp 0.00% +0.000 pp USD30.61 -59.4% 46 qtrs
36 LEEWARD INVESTMENTS, LLC - MA 365.0K -1.9K (-0.5%) 4.53M -724.2K (-13.8%) 0.48% -0.004 pp 0.23% -0.039 pp USD44.42 -72.0% 16 qtrs
37 BNP PARIBAS ARBITRAGE, SNC 356.8K +57.8K (+19.3%) 4.43M +147.1K (+3.4%) 0.46% +0.074 pp 0.00% 0.000 pp USD13.82 -10.1% 51 qtrs
38 TWO SIGMA INVESTMENTS, LP 353.3K -166.1K (-32.0%) 4.39M -3.1M (-41.0%) 0.46% -0.219 pp 0.01% -0.005 pp USD27.35 -54.6% 16 qtrs
39 RAYMOND JAMES FINANCIAL INC 267.1K +48.6K (+22.2%) 3.32M +186.3K (+6.0%) 0.35% +0.062 pp 0.00% +0.000 pp USD15.44 -19.6% 5 qtrs
40 CITADEL ADVISORS LLC 255.8K +255.8K (+100.0%) 3.18M +3.2M (+100.0%) 0.33% +0.333 pp 0.00% +0.001 pp USD12.42 +0.0% 31 qtrs
41 PUBLIC SECTOR PENSION INVESTMENT BOARD 232.2K -29.2K (-11.2%) 2.88M -861.5K (-23.0%) 0.30% -0.039 pp 0.01% -0.004 pp USD24.21 -48.7% 7 qtrs
42 TREXQUANT INVESTMENT LP 230.5K +230.5K (+100.0%) 2.86M +2.9M (+100.0%) 0.30% +0.300 pp 0.03% +0.026 pp USD12.42 +0.0% 1 qtrs NEW
43 LSV ASSET MANAGEMENT 221.3K +— (+0.0%) 2.75M -422.0K (-13.3%) 0.29% -0.001 pp 0.01% -0.001 pp USD18.73 -33.7% 6 qtrs
44 JANE STREET GROUP, LLC 200.2K +180.6K (+921.4%) 2.49M +2.2M (+785.3%) 0.26% +0.235 pp 0.00% +0.000 pp USD12.63 -1.7% 23 qtrs
45 HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 196.3K +196.3K (+100.0%) 2.44M +2.4M (+100.0%) 0.26% +0.256 pp 0.00% +0.004 pp USD12.42 +0.0% 1 qtrs NEW
46 UBS ASSET MANAGEMENT AMERICAS INC 196.2K -6.8K (-3.3%) 2.44M -471.7K (-16.2%) 0.26% -0.010 pp 0.00% 0.000 pp USD32.15 -61.4% 74 qtrs
47 TWO SIGMA ADVISERS, LP 194.3K -176.7K (-47.6%) 2.41M -2.9M (-54.6%) 0.25% -0.232 pp 0.00% -0.006 pp USD48.01 -74.1% 17 qtrs
48 RHUMBLINE ADVISERS 191.9K -9.9K (-4.9%) 2.38M -508.1K (-17.6%) 0.25% -0.014 pp 0.00% 0.000 pp USD37.77 -67.1% 51 qtrs
49 NUVEEN, LLC 186.1K -14.7K (-7.3%) 2.31M -566.3K (-19.7%) 0.24% -0.020 pp 0.00% 0.000 pp USD21.99 -43.5% 4 qtrs
50 TEJARA CAPITAL LTD 171.8K +51.3K (+42.6%) 2.13M +407.0K (+23.6%) 0.22% +0.066 pp 0.50% -0.399 pp USD15.24 -18.5% 4 qtrs
51 VICTORY CAPITAL MANAGEMENT INC 171.3K +99.4K (+138.2%) 2.13M +1.1M (+106.5%) 0.22% +0.129 pp 0.00% +0.001 pp USD14.40 -13.8% 26 qtrs
52 MILLENNIUM MANAGEMENT LLC 149.0K -76.0K (-33.8%) 1.85M -1.4M (-42.6%) 0.19% -0.100 pp 0.00% -0.001 pp USD17.10 -27.4% 33 qtrs
53 BALYASNY ASSET MANAGEMENT L.P. 136.3K +111.2K (+442.5%) 1.69M +1.3M (+370.2%) 0.18% +0.145 pp 0.00% +0.002 pp USD12.77 -2.7% 2 qtrs
54 SWISS NATIONAL BANK 130.7K +2.7K (+2.1%) 1.62M -210.9K (-11.5%) 0.17% +0.003 pp 0.00% 0.000 pp USD39.35 -68.4% 51 qtrs
55 OLSTEIN CAPITAL MANAGEMENT, L.P. 123.0K -16.0K (-11.5%) 1.53M -464.0K (-23.3%) 0.16% -0.022 pp 0.31% -0.063 pp USD29.34 -57.7% 27 qtrs
56 AMERIPRISE FINANCIAL INC 120.1K -5.9K (-4.7%) 1.49M -314.2K (-17.4%) 0.16% -0.008 pp 0.00% 0.000 pp USD26.77 -53.6% 55 qtrs
57 AQR CAPITAL MANAGEMENT LLC 119.5K -11.1K (-8.5%) 1.48M -315.4K (-17.5%) 0.16% -0.015 pp 0.00% 0.000 pp USD24.91 -50.1% 27 qtrs
58 AMERICAN CENTURY COMPANIES INC 118.9K +7.3K (+6.6%) 1.48M -122.3K (-7.6%) 0.15% +0.009 pp 0.00% 0.000 pp USD23.05 -46.1% 16 qtrs
59 IEQ CAPITAL, LLC 110.9K +99.2K (+843.3%) 1.38M +1.2M (+717.6%) 0.14% +0.129 pp 0.00% +0.004 pp USD12.62 -1.6% 2 qtrs
60 BARCLAYS PLC 104.6K -80.3K (-43.4%) 1.30M -2.1M (-61.3%) 0.14% -0.106 pp 0.00% -0.001 pp USD20.39 -39.1% 51 qtrs
61 HRT FINANCIAL LP 102.9K +102.9K (+100.0%) 1.28M +1.3M (+100.0%) 0.13% +0.134 pp 0.00% +0.004 pp USD12.42 +0.0% 1 qtrs NEW
62 EXODUSPOINT CAPITAL MANAGEMENT, LP 101.4K +101.4K (+100.0%) 1.26M +1.3M (+100.0%) 0.13% +0.132 pp 0.01% +0.010 pp USD12.42 +0.0% 1 qtrs NEW
63 ALLIANCEBERNSTEIN L.P. 99.6K +19.3K (+24.1%) 1.24M +86.6K (+7.5%) 0.13% +0.025 pp 0.00% +0.000 pp USD48.85 -74.6% 61 qtrs
64 VERITION FUND MANAGEMENT LLC 96.1K +65.6K (+215.9%) 1.19M +757.3K (+173.8%) 0.13% +0.085 pp 0.00% +0.003 pp USD12.37 +0.4% 8 qtrs
65 VILLANOVA INVESTMENT MANAGEMENT CO LLC 82.8K -629.0 (-0.8%) 1.03M -167.2K (-14.0%) 0.11% -0.001 pp 0.73% -0.104 pp USD16.34 -24.0% 7 qtrs
66 NEW YORK STATE TEACHERS RETIREMENT SYSTEM 81.2K +— (+0.0%) 1.01M -155.0K (-13.3%) 0.11% 0.000 pp 0.00% 0.000 pp USD27.44 -54.7% 51 qtrs
67 ENGINEERS GATE MANAGER LP 79.7K +79.7K (+100.0%) 989.3K +989.3K (+100.0%) 0.10% +0.104 pp 0.01% +0.012 pp USD12.42 +0.0% 11 qtrs
68 WELLS FARGO & COMPANY/MN 78.5K +23.5K (+42.7%) 975.4K +186.6K (+23.7%) 0.10% +0.030 pp 0.00% +0.000 pp USD33.93 -63.4% 57 qtrs
69 UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH 78.4K +— (+0.0%) 973.4K -149.7K (-13.3%) 0.10% 0.000 pp 0.00% 0.000 pp USD22.42 -44.6% 5 qtrs
70 WALLEYE CAPITAL LLC 72.4K +72.4K (+100.0%) 899.1K +899.1K (+100.0%) 0.09% +0.094 pp 0.00% +0.003 pp USD12.42 +0.0% 1 qtrs NEW
71 HSBC HOLDINGS PLC 70.3K +70.3K (+100.0%) 878.6K +878.6K (+100.0%) 0.09% +0.092 pp 0.00% +0.000 pp USD12.42 +0.0% 1 qtrs NEW
72 SUMMIT TRAIL ADVISORS, LLC 69.3K +18.0K (+34.9%) 860.9K +124.9K (+17.0%) 0.09% +0.023 pp 0.01% +0.005 pp USD12.31 +0.9% 3 qtrs
73 WINTON GROUP LTD 68.9K -2.9K (-4.1%) 855.3K -173.6K (-16.9%) 0.09% -0.004 pp 0.03% -0.009 pp USD21.99 -43.5% 4 qtrs
74 COMERICA BANK 65.9K +8.4K (+14.6%) 819.0K -5.3K (-0.6%) 0.09% +0.011 pp 0.00% +0.000 pp USD32.71 -62.0% 11 qtrs
75 SUMMERHAVEN INVESTMENT MANAGEMENT, LLC 64.8K +— (+0.0%) 804.4K -123.7K (-13.3%) 0.08% 0.000 pp 0.46% -0.084 pp USD14.33 -13.3% 2 qtrs
76 PRUDENTIAL FINANCIAL INC 64.3K -4.6K (-6.7%) 799.1K -189.0K (-19.1%) 0.08% -0.006 pp 0.00% 0.000 pp USD22.76 -45.4% 85 qtrs
77 CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 63.4K -8.1K (-11.4%) 787.7K -237.8K (-23.2%) 0.08% -0.011 pp 0.00% 0.000 pp USD32.00 -61.2% 52 qtrs
78 PRICE T ROWE ASSOCIATES INC /MD/ 63.1K +2.6K (+4.3%) 784.0K -83.0K (-9.6%) 0.08% +0.003 pp 0.00% +0.000 pp USD31.75 -60.9% 75 qtrs
79 WEDGE CAPITAL MANAGEMENT L L P/NC 62.7K -2.2K (-3.4%) 778.4K -151.2K (-16.3%) 0.08% -0.003 pp 0.01% -0.002 pp USD37.98 -67.3% 10 qtrs
80 GREAT WEST LIFE ASSURANCE CO /CAN/ 59.4K +— (+0.0%) 737.0K -72.0K (-8.9%) 0.08% 0.000 pp 0.00% +0.000 pp USD44.62 -72.2% 49 qtrs
81 SEI INVESTMENTS CO 59.2K +32.5K (+121.9%) 735.2K +352.9K (+92.3%) 0.08% +0.042 pp 0.00% +0.000 pp USD19.57 -36.5% 45 qtrs
82 BRINKER CAPITAL INVESTMENTS, LLC 58.0K +15.7K (+37.2%) 720.9K +114.5K (+18.9%) 0.08% +0.020 pp 0.01% +0.001 pp USD18.07 -31.3% 5 qtrs
83 MOORE CAPITAL MANAGEMENT, LP 53.3K -1.9K (-3.5%) 662.4K -129.7K (-16.4%) 0.07% -0.003 pp 0.01% -0.001 pp USD12.27 +1.2% 3 qtrs
84 EXCHANGE TRADED CONCEPTS, LLC 51.0K +13.8K (+37.0%) 633.1K +99.8K (+18.7%) 0.07% +0.018 pp 0.00% +0.000 pp USD28.49 -56.4% 25 qtrs
85 HEADLANDS TECHNOLOGIES LLC 50.2K +17.5K (+53.4%) 623.0K +154.4K (+33.0%) 0.07% +0.023 pp 0.05% +0.015 pp USD15.95 -22.1% 11 qtrs
86 SAPIENCE INVESTMENTS, LLC 47.4K +7.4K (+18.5%) 588.5K +15.3K (+2.7%) 0.06% +0.009 pp 2.22% -0.025 pp USD30.35 -59.1% 28 qtrs
87 THRIVENT FINANCIAL FOR LUTHERANS 46.0K -2.3K (-4.8%) 572.0K -121.0K (-17.5%) 0.06% -0.003 pp 0.00% 0.000 pp USD30.28 -59.0% 74 qtrs
88 CLEARLINE CAPITAL LP 43.0K +200.0 (+0.5%) 534.2K -79.3K (-12.9%) 0.06% +0.000 pp 0.03% -0.002 pp USD25.22 -50.8% 11 qtrs
89 CAMPBELL & CO INVESTMENT ADVISER LLC 40.3K +40.3K (+100.0%) 500.5K +500.5K (+100.0%) 0.05% +0.053 pp 0.02% +0.024 pp USD12.42 +0.0% 19 qtrs
90 COUNTERPOINT MUTUAL FUNDS LLC 40.3K +3.1K (+8.3%) 500.1K -32.8K (-6.2%) 0.05% +0.004 pp 0.04% -0.005 pp USD12.45 -0.2% 3 qtrs
91 STRS OHIO 40.1K -8.8K (-18.0%) 498.0K -202.7K (-28.9%) 0.05% -0.012 pp 0.00% -0.001 pp USD14.58 -14.8% 7 qtrs
92 SOUTH DAKOTA INVESTMENT COUNCIL 39.5K -3.3K (-7.7%) 491.0K -122.0K (-19.9%) 0.05% -0.005 pp 0.01% -0.003 pp USD52.56 -76.4% 30 qtrs
93 DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 39.2K -755.7K (-95.1%) 487.0K -10.9M (-95.7%) 0.05% -0.989 pp 0.01% -0.168 pp USD21.99 -43.5% 4 qtrs
94 CREATIVE PLANNING 39.1K +2.7K (+7.5%) 485.3K -35.5K (-6.8%) 0.05% +0.003 pp 0.00% 0.000 pp USD17.64 -29.6% 5 qtrs
95 STATE OF ALASKA, DEPARTMENT OF REVENUE 38.6K +393.0 (+1.0%) 478.0K -69.0K (-12.6%) 0.05% +0.000 pp 0.01% -0.001 pp USD21.37 -41.9% 37 qtrs
96 INSPIRE INVESTING, LLC 37.5K +6.0K (+19.1%) 465.5K +14.5K (+3.2%) 0.05% +0.008 pp 0.04% -0.002 pp USD20.99 -40.8% 18 qtrs
97 METLIFE INVESTMENT MANAGEMENT, LLC 35.8K -5.3K (-12.8%) 444.4K -143.9K (-24.5%) 0.05% -0.007 pp 0.00% -0.001 pp USD34.16 -63.6% 33 qtrs
98 JANUS HENDERSON GROUP PLC 33.8K +— (+0.0%) 418.9K -65.0K (-13.4%) 0.04% 0.000 pp 0.00% +0.000 pp USD57.33 -78.3% 35 qtrs
99 MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 31.2K -287.0 (-0.9%) 387.1K -63.6K (-14.1%) 0.04% -0.001 pp 0.00% 0.000 pp USD18.52 -32.9% 6 qtrs
100 LOUISIANA STATE EMPLOYEES RETIREMENT SYSTEM 30.7K -100.0 (-0.3%) 381.3K -60.1K (-13.6%) 0.04% 0.000 pp 0.01% -0.001 pp USD31.88 -61.0% 49 qtrs
Ownership breakdown by holder

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.72
Neutral
Ratio by volume
3.00
Bullish
Buys
13
Sells
18
Shares acquired
890.1K
Shares disposed
63.0K
Cash buys
Cash sales
Net activity
+827,073
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-03-11 Veillon-Berteloot Chantal Officer F-InKind D Common Stock 5,420 9.61 52.1K 22,227 D
2026-03-11 Singh Harvinder Officer A-Award A Restricted Stock Units 60,865 0.00 63,293 D
2026-03-11 Poul Mojdeh Director / Officer A-Award A Restricted Stock Units 343,393 0.00 445,691 D
2026-03-11 Mosebrook Jeffrey Officer A-Award A Restricted Stock Units 15,957 0.00 15,957 D
2026-03-11 McBreen Michael J. Officer F-InKind D Common Stock 7,247 9.61 69.6K 60,743 D
2026-03-11 Knight Lea Daniels Officer A-Award A Restricted Stock Units 111,179 0.00 111,179 D
2026-03-11 Hutchinson Michael Damon Officer A-Award A Restricted Stock Units 70,305 0.00 159,911 D
2026-03-11 DAVIS ROBERT T. JR. Officer A-Award A Restricted Stock Units 43,350 0.00 43,350 D
2026-03-10 Singh Harvinder Officer M-Exempt D Restricted Stock Units 1,216 0.00 21,350 D
2026-03-10 Mosebrook Jeffrey Officer F-InKind D Common Stock 341 9.55 3.3K 36,259 D
2026-03-10 McBreen Michael J. Officer F-InKind D Common Stock 2,354 9.55 22.5K 67,990 D
2026-03-10 DAVIS ROBERT T. JR. Officer F-InKind D Common Stock 687 9.55 6.6K 74,874 D
2026-02-02 Hutchinson Michael Damon Officer A-Award A Restricted Stock Units 89,606 0.00 89,606 D
2026-01-27 Hutchinson Michael Damon Officer 0 0.00 0
2026-01-06 Poul Mojdeh Director / Officer M-Exempt D Restricted Stock Units 848 0.00 102,840 D
2025-11-05 GRAVES JEFFREY A Director P-Purchase A Common Stock 9,000 11.35 102.2K 41,086 D
2025-10-12 Singh Harvinder Officer M-Exempt A Common Stock 11,965 0.00 25,217 D
2025-09-01 Veillon-Berteloot Chantal Officer F-InKind D Common Stock 2,139 15.13 32.4K 29,059 D
2025-08-14 ESSIG STUART Director J-Other D Common Stock 200,000 13.62 2.72M 1,152,236 D
2025-07-03 Mosebrook Jeffrey Officer F-InKind D Common Stock 3,345 13.49 45.1K 36,600 D
2025-07-03 Knight Lea Daniels Officer F-InKind D Common Stock 2,561 13.49 34.5K 58,578 D
2025-07-01 Mosebrook Jeffrey Officer F-InKind D Common Stock 937 13.25 12.4K 39,945 D
2025-05-09 SCHADE CHRISTIAN S Director A-Award A Common Stock 6,939 0.00 70,442 D
2025-05-09 Lo Renee Wonlai Director A-Award A Common Stock 19,592 0.00 35,743 D
2025-05-09 HILL BARBARA B Director A-Award A Common Stock 6,939 0.00 107,261 D
2025-05-09 GRAVES JEFFREY A Director A-Award A Common Stock 19,592 0.00 32,086 D
2025-05-09 ESSIG STUART Director / Officer A-Award A Common Stock 6,939 0.00 647,258 D
2025-05-09 Clay Shaundra Director A-Award A Common Stock 19,592 0.00 41,515 D
2025-05-09 BRADLEY KEITH Director F-InKind D Common Stock 392 12.25 4.8K 69,544 D
2025-03-11 Veillon-Berteloot Chantal Officer A-Award A Non- Qualified Stock Option (right to buy) 15,549 23.95 372.4K 15,549 D
2025-03-11 Singh Harvinder Officer M-Exempt D Restricted Stock Units 2,356 0.00 34,531 D
2025-03-11 Schwartz Eric Officer F-InKind D Common Stock 1,180 23.95 28.3K 56,020 D
2025-03-11 Mosebrook Jeffrey Officer F-InKind D Common Stock 309 23.95 7.4K 35,368 D
2025-03-11 McBreen Michael J. Officer A-Award A Non- Qualified Stock Option (right to buy) 39,132 23.95 937.2K 39,132 D
2025-03-11 Knight Lea Daniels Officer F-InKind D Common Stock 1,655 23.95 39.6K 40,280 D
2025-03-11 DAVIS ROBERT T. JR. Officer A-Award A Non- Qualified Stock Option (right to buy) 26,310 23.95 630.1K 26,310 D
2025-03-10 Singh Harvinder Officer M-Exempt D Restricted Stock Units 1,180 0.00 36,887 D
2025-03-10 Schwartz Eric Officer F-InKind D Common Stock 773 22.61 17.5K 58,738 D
2025-03-10 Mosebrook Jeffrey Officer F-InKind D Common Stock 166 22.61 3.8K 35,811 D
2025-03-10 McBreen Michael J. Officer F-InKind D Common Stock 1,056 22.61 23.9K 53,897 D
2025-03-10 DAVIS ROBERT T. JR. Officer F-InKind D Common Stock 592 22.61 13.4K 64,515 D
2025-01-06 Poul Mojdeh Director / Officer A-Award A Non- Qualified Stock Option (right to buy) 217,961 21.70 4.73M 217,961 D
2024-12-03 Schwartz Eric Officer S-Sale D Common Stock 4,070 24.60 100.1K 59,511 D
2024-12-02 McBreen Michael J. Officer S-Sale D Common Stock 1,700 24.16 41.1K 56,182 D
2024-11-01 De Witte Jan Director / Officer M-Exempt A Common Stock 9,814 0.00 28,164 D
2024-09-01 Veillon-Berteloot Chantal Officer F-InKind D Common Stock 1,412 20.34 28.7K 24,379
2024-08-19 Mosebrook Jeffrey Officer S-Sale D Common Stock 1,191 21.58 25.7K 36,088
2024-07-03 Knight Lea Daniels Officer F-InKind D Common Stock 2,561 28.73 73.6K 41,935
2024-07-01 Mosebrook Jeffrey Officer A-Award A Common Stock 10,356 0.00 37,279
2024-05-23 ESSIG STUART Director / Officer P-Purchase A Common Stock 52,641 28.49 1.50M 487,922
2024-05-21 HILL BARBARA B Director P-Purchase A Common Stock 36,350 27.40 995.8K 36,350
2024-05-12 BRADLEY KEITH Director F-InKind D Common Stock 37 25.99 961.63 69,936
2024-05-09 SCHADE CHRISTIAN S Director A-Award A Common Stock 8,696 0.00 63,503
2024-05-09 Murphy Raymond G. Director A-Award A Common Stock 8,696 0.00 54,007
2024-05-09 Lo Renee Wonlai Director A-Award A Common Stock 8,696 0.00 16,151
2024-05-09 HILL BARBARA B Director A-Award A Common Stock 3,163 0.00 91,626
2024-05-09 GRAVES JEFFREY A Director A-Award A Common Stock 1,582 0.00 3,798
2024-05-09 ESSIG STUART Director / Officer A-Award A Common Stock 10,672 0.00 935,281
2024-05-09 Clay Shaundra Director A-Award A Common Stock 8,696 0.00 21,923
2024-05-09 BRADLEY KEITH Director A-Award A Common Stock 8,696 0.00 70,175
2024-03-12 Schwartz Eric Officer F-InKind D Common Stock 348 35.88 12.5K 63,581
2024-03-12 Mosebrook Jeffrey Officer F-InKind D Common Stock 223 35.88 8.0K 27,047
2024-03-12 McBreen Michael J. Officer F-InKind D Common Stock 440 35.88 15.8K 57,882
2024-03-12 DAVIS ROBERT T. JR. Officer F-InKind D Common Stock 443 35.88 15.9K 66,688
2024-03-11 Veillon-Berteloot Chantal Officer A-Award A Non- Qualified Stock Option (right to buy) 8,027 36.22 290.7K 8,027
2024-03-11 Singh Harvinder Officer A-Award A Restricted Stock Units 7,140 0.00 21,501
2024-03-11 Schwartz Eric Officer F-InKind D Common Stock 1,371 36.22 49.7K 48,991
2024-03-11 Mosebrook Jeffrey Officer F-InKind D Common Stock 130 36.22 4.7K 23,860
2024-03-11 McBreen Michael J. Officer A-Award A Common Stock 8,283 0.00 59,894
2024-03-11 Knight Lea Daniels Officer A-Award A Non- Qualified Stock Option (right to buy) 27,308 36.22 989.1K 27,308
2024-03-11 De Witte Jan Director / Officer A-Award A Restricted Stock Units 41,414 0.00 130,485
2024-03-11 DAVIS ROBERT T. JR. Officer A-Award A Common Stock 13,805 0.00 67,131
2024-03-10 Singh Harvinder Officer M-Exempt A Common Stock 1,179 0.00 1,179
2024-03-10 Schwartz Eric Officer F-InKind D Common Stock 799 36.73 29.3K 50,362
2024-03-10 Mosebrook Jeffrey Officer F-InKind D Common Stock 166 36.73 6.1K 23,990
2024-03-10 McBreen Michael J. Officer F-InKind D Common Stock 1,198 36.73 44.0K 43,313
2024-03-10 De Witte Jan Director / Officer F-InKind D Common Stock 346 36.73 12.7K 18,350
2024-03-10 DAVIS ROBERT T. JR. Officer F-InKind D Common Stock 635 36.73 23.3K 49,258
2024-03-06 DAVIS ROBERT T. JR. Officer M-Exempt A Common Stock 8,736 32.59 284.7K 58,241
2024-02-20 Schwartz Eric Officer A-Award A Common Stock 2,564 0.00 51,161
2024-02-20 Mosebrook Jeffrey Officer A-Award A Common Stock 808 0.00 24,266
2024-02-20 McBreen Michael J. Officer A-Award A Common Stock 3,516 0.00 45,968
2024-02-20 DAVIS ROBERT T. JR. Officer A-Award A Common Stock 3,721 0.00 49,505
2024-01-18 De Witte Jan Director / Officer M-Exempt D Restricted Stock Units 597 0.00 89,417
2023-12-12 GRAVES JEFFREY A Director 0 0.00 0
2023-11-01 De Witte Jan Director / Officer M-Exempt A Common Stock 9,814 0.00 22,612
2023-09-01 Veillon-Berteloot Chantal Officer A-Award A Common Stock 4,678 0.00 4,678
2023-08-23 Veillon-Berteloot Chantal Officer 0 0.00 0
2023-08-09 Mosebrook Jeffrey Officer S-Sale D Common Stock 1,177 44.46 52.3K 23,458
2023-07-03 Mosebrook Jeffrey Officer A-Award A Common Stock 12,196 0.00 24,635
2023-07-03 Knight Lea Daniels Officer A-Award A Common Stock 18,293 0.00 18,293
2023-06-28 Knight Lea Daniels Officer 0 0.00 0
2023-06-01 Schwartz Eric Officer P-Purchase A Common Stock 2,640 37.89 100.0K 48,597
2023-06-01 De Witte Jan Director / Officer P-Purchase A Common Stock 7,792 38.50 300.0K 12,798
2023-05-13 BRADLEY KEITH Director F-InKind D Common Stock 29 49.05 1.4K 61,635
2023-05-12 SCHADE CHRISTIAN S Director A-Award A Common Stock 4,486 0.00 54,807
2023-05-12 Murphy Raymond G. Director A-Award A Common Stock 4,486 0.00 45,311
2023-05-12 Lo Renee Wonlai Director A-Award A Common Stock 4,486 0.00 7,455
2023-05-12 HILL BARBARA B Director A-Award A Common Stock 4,486 0.00 88,463
2023-05-12 ESSIG STUART Director A-Award A Common Stock 5,505 0.00 1,152,329
2023-05-12 Clay Shaundra Director A-Award A Common Stock 4,486 0.00 13,227
2023-05-12 BRADLEY KEITH Director A-Award A Common Stock 816 0.00 61,664
2023-03-13 Schwartz Eric Officer F-InKind D Common Stock 416 62.61 26.0K 45,957
2023-03-13 Mosebrook Jeffrey Officer F-InKind D Common Stock 64 52.61 3.4K 12,439
2023-03-13 McBreen Michael J. Officer F-InKind D Common Stock 655 52.61 34.5K 42,750
2023-03-13 Evoli Lisa Officer F-InKind D Common Stock 300 52.61 15.8K 18,446
2023-03-13 DAVIS ROBERT T. JR. Officer F-InKind D Common Stock 1,010 52.61 53.1K 45,784
2023-03-12 Schwartz Eric Officer F-InKind D Common Stock 338 52.87 17.9K 47,288
2023-03-12 Mosebrook Jeffrey Officer F-InKind D Common Stock 106 52.87 5.6K 12,828
2023-03-12 McBreen Michael J. Officer F-InKind D Common Stock 751 52.87 39.7K 44,283
2023-03-12 Evoli Lisa Officer F-InKind D Common Stock 448 52.87 23.7K 19,929
2023-03-12 DAVIS ROBERT T. JR. Officer F-InKind D Common Stock 755 52.87 39.9K 47,253
2023-03-11 Schwartz Eric Officer F-InKind D Common Stock 2,393 52.87 126.5K 49,829
2023-03-11 Mosebrook Jeffrey Officer F-InKind D Common Stock 130 52.87 6.9K 12,934
2023-03-11 McBreen Michael J. Officer F-InKind D Common Stock 857 52.87 45.3K 45,525
2023-03-11 Evoli Lisa Officer F-InKind D Common Stock 277 52.87 14.6K 20,377
2023-03-11 De Witte Jan Director / Officer M-Exempt D Restricted Stock Units 205 0.00 99,828
2023-03-11 DAVIS ROBERT T. JR. Officer F-InKind D Common Stock 458 52.87 24.2K 49,689
2023-03-10 Singh Harvinder Officer A-Award A Non-Qualified Stock Option (right to buy) 8,990 52.87 475.3K 8,990
2023-03-10 Schwartz Eric Officer A-Award A Non-Qualified Stock Option (right to buy) 12,419 52.87 656.6K 12,419
2023-03-10 Mosebrook Jeffrey Officer A-Award A Common Stock 1,256 0.00 13,177
2023-03-10 McBreen Michael J. Officer A-Award A Common Stock 8,128 0.00 46,382
2023-03-10 Evoli Lisa Officer A-Award A Non-Qualified Stock Option (right to buy) 6,201 52.87 327.8K 6,201
2023-03-10 De Witte Jan Director / Officer A-Award A Non-Qualified Stock Option (right to buy) 63,717 52.87 3.37M 63,717
2023-03-10 DAVIS ROBERT T. JR. Officer A-Award A Common Stock 4,227 0.00 50,147
2023-03-07 McBreen Michael J. Officer S-Sale D Common Stock 1,843 54.29 100.1K 28,796
2023-03-02 McBreen Michael J. Officer F-InKind D Common Stock 723 55.09 39.8K 30,639
2023-03-01 DAVIS ROBERT T. JR. Officer S-Sale D Common Stock 1,566 55.21 86.5K 45,920
2023-02-27 Evoli Lisa Officer S-Sale D Common Stock 3,767 57.00 214.7K 18,605
2023-02-13 Schwartz Eric Officer A-Award A Common Stock 5,641 0.00 47,152
2023-02-13 Mosebrook Jeffrey Officer A-Award A Common Stock 510 0.00 9,062
2023-02-13 McBreen Michael J. Officer A-Award A Common Stock 1,680 0.00 29,443
2023-02-13 Evoli Lisa Officer A-Award A Common Stock 1,552 0.00 19,549
2023-02-13 De Witte Jan Director / Officer A-Award A Common Stock 8,848 0.00 8,848
2023-02-13 DAVIS ROBERT T. JR. Officer A-Award A Common Stock 1,067 0.00 42,258
2023-01-18 De Witte Jan Officer M-Exempt A Common Stock 431 0.00 431
2022-12-08 Mosebrook Jeffrey Officer S-Sale D Common Stock 279 56.22 15.7K 8,552
2022-11-01 De Witte Jan Officer A-Award A Restricted Stock Units 29,441 0.00 74,456
2022-10-31 ESSIG STUART Director I Common Stock 0 0.00 0
2022-10-12 Singh Harvinder Officer A-Award A Restricted Stock Units 11,965 0.00 11,965
2022-10-03 Singh Harvinder Officer 0 0.00 0
2022-08-10 Evoli Lisa Officer S-Sale D Common Stock 1,165 55.81 65.0K 17,997
2022-08-05 Murphy Raymond G. Director S-Sale D Common Stock 8,000 55.78 446.3K 40,825
2022-08-03 Evoli Lisa Officer F-InKind D Common Stock 293 55.34 16.2K 19,162
2022-08-02 Mosebrook Jeffrey Officer S-Sale D Common Stock 437 56.78 24.8K 8,831
2022-08-01 McBreen Michael J. Officer F-InKind D Common Stock 599 56.87 34.1K 25,289
2022-08-01 Evoli Lisa Officer F-InKind D Common Stock 456 56.87 25.9K 19,455
2022-07-27 Lo Renee Wonlai Director A-Award A Common Stock 2,969 0.00 2,969
2022-07-18 Lo Renee Wonlai Director 0 0.00 0
2022-07-01 Coleman Glenn Officer F-InKind D Common Stock 6,666 55.00 366.6K 34,622
2022-07-01 Anderson Carrie L Officer F-InKind D Common Stock 4,425 55.00 243.4K 57,811
2022-06-15 Evoli Lisa Officer S-Sale D Common Stock 900 55.93 50.3K 19,911
2022-05-24 Evoli Lisa Officer S-Sale D Common Stock 250 59.85 15.0K 20,811
2022-05-13 SCHADE CHRISTIAN S Director A-Award A Common Stock 3,456 0.00 50,321
2022-05-13 Murphy Raymond G. Director A-Award A Common Stock 3,456 0.00 48,825
2022-05-13 MOREL DONALD E JR Director A-Award A Common Stock 3,456 0.00 55,753
2022-05-13 HILL BARBARA B Director A-Award A Common Stock 3,456 0.00 82,346
2022-05-13 ESSIG STUART Director A-Award A Common Stock 4,215 0.00 1,146,824
2022-05-13 Clay Shaundra Director A-Award A Common Stock 3,456 0.00 8,741
2022-05-13 BRADLEY KEITH Director F-InKind D Common Stock 131 59.32 7.8K 56,362
2022-04-04 Coleman Glenn Officer S-Sale D Common Stock 6,268 66.04 413.9K 41,288
2022-03-23 Tru St Partnership, L.P. 10% Owner S-Sale D Common Stock 150,000 64.67 9.70M 8,515,930
2022-03-13 Schwartz Eric Officer F-InKind D Common Stock 691 65.11 45.0K 38,883
2022-03-13 Mosebrook Jeffrey Officer F-InKind D Common Stock 44 65.11 2.9K 9,726
2022-03-13 Evoli Lisa Officer F-InKind D Common Stock 430 65.11 28.0K 21,765
2022-03-13 DAVIS ROBERT T. JR. Officer F-InKind D Common Stock 297 65.11 19.3K 40,703
2022-03-13 Anderson Carrie L Officer F-InKind D Common Stock 807 65.11 52.5K 64,532
2022-03-12 Schwartz Eric Officer F-InKind D Common Stock 349 65.11 22.7K 40,264
2022-03-12 Mosebrook Jeffrey Officer F-InKind D Common Stock 120 65.11 7.8K 10,154
2022-03-12 Evoli Lisa Officer F-InKind D Common Stock 394 65.11 25.7K 23,155
2022-03-12 DAVIS ROBERT T. JR. Officer F-InKind D Common Stock 1,109 65.11 72.2K 42,000
2022-03-12 Anderson Carrie L Officer F-InKind D Common Stock 436 65.11 28.4K 67,781
2022-03-11 Schwartz Eric Officer F-InKind D Common Stock 1,488 65.11 96.9K 37,395
2022-03-11 Mosebrook Jeffrey Officer F-InKind D Common Stock 240 65.11 15.6K 9,914
2022-03-11 McBreen Michael J. Officer F-InKind D Common Stock 1,083 65.11 70.5K 25,888
2022-03-11 Evoli Lisa Officer A-Award A Non-Qualified Stock Option (right to buy) 5,553 65.11 361.6K 5,553
2022-03-11 De Witte Jan Officer A-Award A Restricted Stock Units 15,359 0.00 45,015
2022-03-11 DAVIS ROBERT T. JR. Officer A-Award A Non-Qualified Stock Option (right to buy) 9,193 65.11 598.6K 9,193
2022-03-11 Coleman Glenn Officer F-InKind D Common Stock 5,338 65.11 347.6K 47,556
2022-03-11 Anderson Carrie L Officer A-Award A Common Stock 11,519 0.00 68,217
2022-03-02 McBreen Michael J. Officer F-InKind D Common Stock 466 67.59 31.5K 19,261
2022-03-01 Schwartz Eric Officer F-InKind D Common Stock 1,712 66.32 113.5K 31,912
2022-02-28 Evoli Lisa Officer S-Sale D Common Stock 1,254 67.03 84.1K 14,058
2022-02-11 Schwartz Eric Officer A-Award A Common Stock 2,520 0.00 25,605
2022-02-11 Mosebrook Jeffrey Officer A-Award A Common Stock 595 0.00 6,603
2022-02-11 McBreen Michael J. Officer A-Award A Common Stock 1,458 0.00 11,195
2022-02-11 Evoli Lisa Officer A-Award A Common Stock 1,566 0.00 8,916
2022-02-11 DAVIS ROBERT T. JR. Officer A-Award A Common Stock 2,956 0.00 25,107
2022-02-11 Coleman Glenn Officer A-Award A Common Stock 5,892 0.00 34,046
2022-02-11 Anderson Carrie L Officer A-Award A Common Stock 8,904 0.00 50,462
2022-02-09 Tru St Partnership, L.P. 10% Owner S-Sale D Common Stock 75,000 65.82 4.94M 8,665,930
2022-01-18 De Witte Jan Director / Officer A-Award A Restricted Stock Units 29,656 0.00 29,656
2021-12-16 Tru St Partnership, L.P. 10% Owner S-Sale D Common Stock 75,000 64.28 4.82M 8,740,930
2021-12-03 Schwartz Eric Officer F-InKind D Common Stock 2,414 62.69 151.3K 23,085
2021-12-01 De Witte Jan Director / Officer 0 0.00 0
2021-11-18 Tru St Partnership, L.P. 10% Owner S-Sale D Common Stock 75,000 68.59 5.14M 8,815,930
2021-11-10 Mosebrook Jeffrey Officer S-Sale D Common Stock 700 70.88 49.6K 6,008
2021-11-05 McBreen Michael J. Officer S-Sale D Common Stock 3,450 71.59 247.0K 9,737
2021-11-02 Coleman Glenn Officer S-Sale D Common Stock 4,275 74.00 316.4K 27,781
2021-10-20 Tru St Partnership, L.P. 10% Owner S-Sale D Common Stock 200,000 69.81 13.96M 8,890,930

Executive team

Top executives
EBIT / Employee
-108.6K
Shares Outstanding
77.94M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2025 Mojdeh Poul President and Chief Executive Officer and Director 1.01M 350.4K 5.22M 2.25M 174.6K 371.1K 9.38M 79.67%
2 2025 Lea Knight Executive Vice President and Chief Financial Officer 638.6K 154.9K 1.50M 499.6K 77.2K 14.0K 2.88M 69.31%
3 2025 Michael J. McBreen Executive Vice President, President, Codman Specialty Surgical 643.8K 212.4K 1.33M 442.6K 72.8K 14.0K 2.71M 65.25%
4 2025 Robert T. Davis, Jr Executive Vice President, President, Tissue Technologies 583.4K 69.6K 892.7K 297.6K 55.4K 14.0K 1.91M 62.23%
5 2025 Harvinder Singh Executive Vice President, President, International 564.0K 91.2K 683.1K 227.7K 45.4K 14.0K 1.63M 56.04%
6 2025 Jan De Witte Former President and Chief Executive Officer and Director 42.3K 240.4K 282.7K 0.00%
7 2024 Jan De Witte Former President and Chief Executive Officer and Director 969.0K 4.50M 1.50M 491.3K 34.4K 7.49M 80.06%
8 2024 Jan De Witte President and Chief Executive Officer and Director 969.0K 4.50M 1.50M 491.3K 34.4K 7.49M 80.06%
9 2024 Michael J. McBreen Executive Vice President, President, Codman Specialty Surgical 638.7K 222.7K 1.63M 442.6K 215.0K 13.5K 3.16M 65.51%
10 2024 Lea Knight Executive Vice President and Chief Financial Officer 616.7K 281.9K 1.58M 428.2K 220.3K 13.8K 3.15M 63.99%
11 2024 Harvinder Singh Executive Vice President, President, International 511.1K 134.3K 1.38M 258.6K 129.7K 214.6K 2.62M 62.28%
12 2024 Robert T. Davis, Jr Executive Vice President, President, Tissue Technologies 544.9K 134.8K 1.20M 234.6K 130.2K 13.8K 2.26M 63.59%
13 2023 Jan De Witte President and Chief Executive Officer and Director 875.5K 4.13M 1.38M 13.2K 6.39M 86.09%
14 2023 Jan De Witte Former President and Chief Executive Officer and Director 875.5K 4.13M 1.38M 13.2K 6.39M 86.09%
15 2023 Michael J. McBreen Executive Vice President, President, Codman Specialty Surgical 598.1K 1.79M 429.7K 13.2K 2.83M 78.40%
16 2023 Lea Knight Executive Vice President and Chief Financial Officer 295.4K 350.0K 1.00M 27.8K 1.67M 59.77%
17 2023 Eric I. Schwartz Executive Vice President, Chief Legal Officer & Secretary 536.3K 804.1K 268.0K 13.2K 1.62M 66.11%
18 2023 Robert T. Davis, Jr Executive Vice President, President, Tissue Technologies 516.0K 670.4K 223.4K 13.1K 1.42M 62.82%
19 2023 Jeffrey Mosebrook Senior Vice President, Finance and Interim PFO 368.1K 111.9K 760.2K 13.2K 1.25M 60.65%
20 2023 Carrie L. Anderson Former Executive Vice President and Chief Financial Officer 64.7K 2.6K 67.3K 0.00%
21 2022 Jan De Witte President and Chief Executive Officer and Director 850.0K 6.50M 1.00M 813.5K 156.4K 9.32M 80.47%
22 2022 Glenn G. Coleman Former Executive Vice President and Chief Operating Officer 463.5K 1.39M 463.5K 430.1K 1.68M 4.43M 41.89%
23 2022 Eric I. Schwartz Executive Vice President, Chief Legal Officer & Secretary 525.0K 1.91M 637.5K 310.0K 12.2K 3.40M 75.06%
24 2022 Carrie L. Anderson Former Executive Vice President and Chief Financial Officer 565.4K 1.97M 406.0K 12.2K 2.95M 80.43%
25 2022 Michael J. McBreen Executive Vice President, President, Codman Specialty Surgical 494.5K 1.15M 216.9K 274.1K 12.2K 2.15M 63.66%
26 2022 Robert T. Davis, Jr Executive Vice President, President, Tissue Technologies 498.0K 938.5K 212.8K 271.0K 12.2K 1.93M 59.57%
27 2021 Peter J. Arduini President and Chief Executive Officer and Director 956.3K 5.75M 1.50M 1.62M 11.6K 9.84M 73.69%
28 2021 Glenn G. Coleman Executive Vice President and Chief Operating Officer 613.3K 1.76M 463.5K 688.0K 11.3K 3.54M 62.90%
29 2021 Glenn G. Coleman Former Executive Vice President and Chief Operating Officer 613.3K 1.76M 463.5K 688.0K 11.3K 3.54M 62.90%
30 2021 Carrie L. Anderson Former Executive Vice President and Chief Financial Officer 518.5K 1.25M 328.1K 515.0K 28.1K 2.64M 59.74%
31 2021 Carrie L. Anderson Executive Vice President and Chief Financial Officer 518.5K 1.25M 328.1K 515.0K 28.1K 2.64M 59.74%
32 2021 Robert T. Davis, Jr Executive Vice President, President, Tissue Technologies 487.0K 876.0K 208.6K 375.0K 11.3K 1.96M 55.39%
33 2021 Michael J. McBreen Executive Vice President, President, Codman Specialty Surgical 460.0K 827.5K 197.0K 385.0K 10.9K 1.88M 54.48%
34 2021 Jan D. De Witte President and Chief Executive Officer and Director 58.8K 144.4K 48.5K 251.8K 0.00%
35 2021 Jan De Witte President and Chief Executive Officer and Director 58.8K 144.4K 48.5K 251.8K 0.00%
36 2020 Peter J. Arduini President and Chief Executive Officer and Director 848.1K 4.20M 1.80M 882.0K 10.6K 7.74M 77.51%
37 2020 Glenn G. Coleman Executive Vice President and Chief Operating Officer 559.6K 1.33M 570.0K 360.0K 8.3K 2.83M 67.19%
38 2020 Glenn G. Coleman Former Executive Vice President and Chief Operating Officer 559.6K 1.33M 570.0K 360.0K 8.3K 2.83M 67.19%
39 2020 Carrie L. Anderson Former Executive Vice President and Chief Financial Officer 466.3K 875.0K 375.0K 262.5K 81.9K 2.06M 60.66%
40 2020 Carrie L. Anderson Executive Vice President and Chief Financial Officer 466.3K 875.0K 375.0K 262.5K 81.9K 2.06M 60.66%
41 2020 Robert T. Davis, Jr Executive Vice President, President, Tissue Technologies 449.6K 483.1K 207.0K 214.5K 11.4K 1.37M 50.53%
42 2020 Michael J. McBreen Executive Vice President, President, Codman Specialty Surgical 385.3K 547.6K 127.5K 202.5K 11.4K 1.27M 52.98%
43 2019 Peter J. Arduini President and Chief Executive Officer and Director 975.0K 3.99M 1.71M 1.18M 8.4K 7.86M 72.52%
44 2019 Glenn G. Coleman Executive Vice President and Chief Operating Officer 585.4K 1.65M 387.5K 482.0K 11.2K 3.12M 65.43%
45 2019 Carrie L. Anderson Executive Vice President and Chief Financial Officer 259.6K 225.0K 1.70M 205.0K 16.3K 2.41M 70.66%
46 2019 Eric I. Schwartz Executive Vice President, Chief Legal Officer and Secretary 425.0K 1.39M 165.8K 256.3K 11.2K 2.25M 69.15%
47 2019 Robert T. Davis, Jr Executive Vice President, President, Orthopedics and Tissue Technologies 473.2K 453.6K 194.4K 258.0K 11.2K 1.39M 46.60%
48 2019 Robert T. Davis, Jr Executive Vice President, President, Tissue Technologies 473.2K 453.6K 194.4K 258.0K 11.2K 1.39M 46.60%
49 2019 Daniel L. Reuvers Executive Vice President, President, Codman Surgical Solutions 445.3K 416.6K 178.5K 290.0K 11.2K 1.34M 44.36%
50 2018 Peter J. Arduini President and Chief Executive Officer and Director 947.9K 3.82M 1.64M 1.23M 17.2K 7.65M 71.26%
51 2018 Richard D. Gorelick Former Corporate Vice President, General Counsel, Administration and Secretary 406.1K 245.1K 105.0K 2.01M 2.77M 12.65%
52 2018 Glenn G. Coleman Corporate Vice President and Chief Financial Officer 556.2K 869.4K 372.6K 480.7K 15.7K 2.29M 54.13%
53 2018 Glenn G. Coleman Executive Vice President and Chief Operating Officer 556.2K 869.4K 372.6K 480.7K 15.7K 2.29M 54.13%
54 2018 Daniel L. Reuvers Corporate Vice President, President, Codman Surgical Solutions 418.9K 892.1K 168.0K 326.0K 13.4K 1.82M 58.30%
55 2018 Daniel L. Reuvers Executive Vice President, President, Codman Surgical Solutions 418.9K 892.1K 168.0K 326.0K 13.4K 1.82M 58.30%
56 2018 Robert T. Davis, Jr Executive Vice President, President, Tissue Technologies 458.4K 437.6K 187.5K 272.0K 14.0K 1.37M 45.65%
57 2018 Robert T. Davis, Jr Executive Vice President, President, Orthopedics and Tissue Technologies 458.4K 437.6K 187.5K 272.0K 14.0K 1.37M 45.65%
58 2018 Robert T. Davis, Jr Corporate Vice President, President, Orthopedics and Tissue Technologies 458.4K 437.6K 187.5K 272.0K 14.0K 1.37M 45.65%
59 2018 Eric I. Schwartz Corporate Vice President, General Counsel and Secretary 57.2K 900.0K 180.0K 1.14M 79.14%
60 2018 Eric I. Schwartz Executive Vice President, Chief Legal Officer and Secretary 57.2K 180.0K 900.0K 1.14M 79.14%
61 2017 Peter J. Arduini President and Chief Executive Officer and Director 905.0K 3.33M 1.43M 1.46M 16.1K 7.13M 66.58%
62 2017 Glenn G. Coleman Corporate Vice President and Chief Financial Officer 536.3K 805.0K 345.0K 590.0K 11.0K 2.29M 50.28%
63 2017 Glenn G. Coleman Executive Vice President and Chief Operating Officer 536.3K 805.0K 345.0K 590.0K 11.0K 2.29M 50.28%
64 2017 Robert T. Davis, Jr Corporate Vice President, President, Orthopedics and Tissue Technologies 441.3K 437.5K 187.5K 360.0K 8.0K 1.43M 43.58%
65 2017 Robert T. Davis, Jr Executive Vice President, President, Orthopedics and Tissue Technologies 441.3K 437.5K 187.5K 360.0K 8.0K 1.43M 43.58%
66 2017 Daniel L. Reuvers Corporate Vice President, President, Codman Surgical Solutions 407.3K 262.6K 112.5K 375.0K 117.7K 1.28M 29.42%
67 2017 Daniel L. Reuvers Executive Vice President, President, Codman Surgical Solutions 407.3K 262.6K 112.5K 375.0K 117.7K 1.28M 29.42%
68 2017 Richard D. Gorelick Former Corporate Vice President, General Counsel, Administration and Secretary 394.7K 220.5K 94.5K 315.0K 11.6K 1.04M 30.40%
69 2017 Richard D. Gorelick Corporate Vice President, General Counsel, Administration and Secretary 394.7K 220.5K 94.5K 315.0K 11.6K 1.04M 30.40%
70 2016 Peter J. Arduini President and Chief Executive Officer and Director 878.8K 3.15M 1.56M 1.40M 9.6K 6.99M 67.28%
71 2016 Glenn G. Coleman Corporate Vice President and Chief Financial Officer 481.6K 490.1K 592.0K 400.0K 10.0K 1.97M 54.83%
72 2016 Robert T. Davis, Jr Corporate Vice President, President, Orthopedics and Tissue Technologies 400.5K 336.1K 415.9K 300.0K 10.9K 1.46M 51.39%
73 2016 Daniel L. Reuvers Corporate Vice President, President, Codman Surgical Solutions 328.2K 133.8K 216.0K 205.0K 20.0K 903.0K 38.74%
74 2016 Daniel L. Reuvers Corporate Vice President, President, Specialty Surgical Solutions 328.2K 133.8K 216.0K 205.0K 20.0K 903.0K 38.74%
75 2016 Richard D. Gorelick Corporate Vice President, General Counsel, Administration and Secretary 384.7K 184.9K 91.3K 206.0K 10.0K 876.8K 31.50%
76 2016 Richard D. Gorelick Former Corporate Vice President, General Counsel, Administration and Secretary 384.7K 184.9K 91.3K 206.0K 10.0K 876.8K 31.50%
77 2015 Peter J. Arduini President and Chief Executive Officer and Director 885.6K 3.05M 2.27M 1.39M 7.8K 7.60M 69.98%
78 2015 Glenn G. Coleman Corporate Vice President and Chief Financial Officer 478.1K 397.0K 480.0K 348.0K 7.8K 1.71M 51.26%
79 2015 Mark Augusti Corporate Vice President, President — Orthopedics and Tissue Technologies 396.3K 95.0K 383.5K 230.4K 7.8K 1.11M 34.46%
80 2015 Richard D. Gorelick Corporate Vice President, General Counsel, Administration and Secretary, Interim Chief Human Resources Officer 388.7K 188.8K 228.1K 190.0K 4.1K 999.7K 41.70%
81 2015 Richard D. Gorelick Corporate Vice President, General Counsel, Administration and Secretary 388.7K 188.8K 228.1K 190.0K 4.1K 999.7K 41.70%
82 2015 Robert T. Davis, Jr Corporate Vice President, President — Specialty Surgical Solutions 391.6K 298.0K 60.5K 232.5K 4.1K 986.7K 36.33%
83 2015 Robert T. Davis, Jr Corporate Vice President, President, Orthopedics and Tissue Technologies 391.6K 298.0K 60.5K 232.5K 4.1K 986.7K 36.33%
84 2014 Peter J. Arduini President and Chief Executive Officer and Director 827.8K 2.45M 1.05M 1.13M 23.3K 5.48M 63.89%
85 2014 Peter J. Arduini President and Chief Executive Officer and Director 827.8K 2.45M 1.05M 1.13M 23.3K 5.48M 63.89%
86 2014 John B. Henneman, III Former Corporate Vice President, Finance and Administration, and Chief Financial Officer 432.9K 1.50M 378.7K 1.07M 3.38M 44.22%
87 2014 Glenn G. Coleman Corporate Vice President and Chief Financial Officer 287.3K 250.0K 980.1K 420.0K 190.0K 2.13M 65.81%
88 2014 Robert D. Paltridge Former Corporate Vice President, President — Advanced Wound Care 180.9K 208.6K 758.5K 1.15M 18.17%
89 2014 Robert T. Davis, Jr Corporate Vice President, President, Orthopedics and Tissue Technologies 344.7K 278.1K 175.0K 104.6K 902.4K 30.82%
90 2014 Robert T. Davis, Jr Corporate Vice President, President — Specialty Surgical Solutions 344.7K 278.1K 175.0K 104.6K 902.4K 30.82%
91 2014 Robert T. Davis, Jr Corporate Vice President, President — Specialty Surgical Solutions 344.7K 278.1K 175.0K 104.6K 902.4K 30.82%
92 2014 Richard D. Gorelick Corporate Vice President, General Counsel, Administration and Secretary 364.2K 251.3K 141.0K 4.1K 760.6K 33.03%
93 2014 Richard D. Gorelick Corporate Vice President, General Counsel, Administration and Secretary 364.2K 251.3K 141.0K 4.1K 760.6K 33.03%
94 2014 Richard D. Gorelick Corporate Vice President, General Counsel, Administration and Secretary, Interim Chief Human Resources Officer 364.2K 251.3K 141.0K 4.1K 760.6K 33.03%
95 2014 John Mooradian Corporate Vice President, Global Operations and Supply 363.0K 248.6K 140.0K 4.1K 755.7K 32.89%
96 2013 Peter J. Arduini President and Chief Executive Officer and Director 787.1K 1.74M 450.0K 3.8K 2.98M 73.45%
97 2013 Peter J. Arduini President and Chief Executive Officer and Director 787.1K 1.74M 450.0K 3.8K 2.98M 73.45%
98 2013 John B. Henneman, III Former Corporate Vice President, Finance and Administration, and Chief Financial Officer 549.4K 1.00M 4.1K 1.55M 64.37%
99 2013 John B. Henneman, III Corporate Vice President, Finance and Administration, and Chief Financial Officer 549.4K 1.00M 4.1K 1.55M 64.37%
100 2013 Robert T. Davis, Jr Corporate Vice President, President — Specialty Surgical Solutions 335.1K 175.1K 4.1K 514.3K 34.04%
101 2013 Robert T. Davis, Jr Corporate Vice President, President — Specialty Surgical Solutions 335.1K 175.1K 4.1K 514.3K 34.04%
102 2013 Robert T. Davis, Jr Corporate Vice President, President — Neurosurgery 335.1K 175.1K 4.1K 514.3K 34.04%
103 2013 Richard D. Gorelick Corporate Vice President, General Counsel, Administration and Secretary, Interim Chief Human Resources Officer 355.7K 139.0K 4.1K 498.8K 27.87%
104 2013 Richard D. Gorelick Corporate Vice President, General Counsel, Administration and Secretary 355.7K 139.0K 4.1K 498.8K 27.87%
105 2013 Brian Larkin Corporate Vice President, President — Global Spine Orthobiologics Head of Strategic Development 336.6K 130.1K 4.1K 470.8K 27.63%
106 2013 John Mooradian Corporate Vice President, Global Operations and Supply 353.7K 110.1K 4.1K 467.8K 23.52%
107 2013 Robert D. Paltridge Former Corporate Vice President, President — Advanced Wound Care 328.0K 125.1K 4.1K 457.1K 27.36%
108 2012 Peter J. Arduini President and Chief Executive Officer and Director 722.1K 4.54M 2.83M 400.0K 17.6K 8.51M 86.61%
109 2012 John B. Henneman, III Former Corporate Vice President, Finance and Administration, and Chief Financial Officer 530.3K 2.20M 275.0K 4.1K 3.01M 73.08%
110 2012 John B. Henneman, III Corporate Vice President, Finance and Administration, and Chief Financial Officer (former Executive Vice President, Finance and Administration, and Chief Financial Officer) 530.3K 2.20M 275.0K 4.1K 3.01M 73.08%
111 2012 John B. Henneman, III Corporate Vice President, Finance and Administration, and Chief Financial Officer 530.3K 2.20M 275.0K 4.1K 3.01M 73.08%
112 2012 John Mooradian Corporate Vice President, Global Operations and Supply 109.0K 300.0K 300.0K 122.0K 831.0K 36.10%
113 2012 John Mooradian Corporate Vice President, Global Operations and Supply 109.0K 300.0K 300.0K 122.0K 831.0K 36.10%
114 2012 Richard D. Gorelick Corporate Vice President, General Counsel, Administration and Secretary 345.2K 180.0K 138.7K 4.1K 668.1K 26.95%
115 2012 Richard D. Gorelick Corporate Vice President, General Counsel, Administration and Secretary 345.2K 180.0K 138.7K 4.1K 668.1K 26.95%
116 2012 Robert D. Paltridge Former Corporate Vice President, President — Advanced Wound Care 318.6K 195.3K 130.0K 4.1K 648.1K 30.14%
117 2012 Robert D. Paltridge Former Corporate Vice President, President — Advanced Wound Care 318.6K 195.3K 130.0K 4.1K 648.1K 30.14%
118 2012 Stuart M. Essig Chairman of the Board of Directors (former Chief Executive Officer and former Executive Chairman of the Board) 343.3K 114.0K 49.4K 506.7K 22.51%
119 2011 Stuart M. Essig Executive Chairman and Former Chief Executive Officer 749.0K 10.72M 2.9K 11.48M 93.45%
120 2011 Stuart M. Essig Chairman of the Board of Directors (former Chief Executive Officer and former Executive Chairman of the Board) 749.0K 10.72M 2.9K 11.48M 93.45%
121 2011 Peter J. Arduini President and Chief Executive Officer 600.0K 400.0K 157.2K 1.16M 0.00%
122 2011 Peter J. Arduini President and Chief Executive Officer and Director 600.0K 400.0K 157.2K 1.16M 0.00%
123 2011 John B. Henneman, III Corporate Vice President, Finance and Administration, and Chief Financial Officer 524.5K 4.1K 528.6K 0.00%
124 2011 John B. Henneman, III Executive Vice President, Finance and Administration, and Chief Financial Officer 524.5K 4.1K 528.6K 0.00%
125 2011 John B. Henneman, III Corporate Vice President, Finance and Administration, and Chief Financial Officer (former Executive Vice President, Finance and Administration, and Chief Financial Officer) 524.5K 4.1K 528.6K 0.00%
126 2011 Jerry E. Corbin Vice President, Corporate Controller and Principal Accounting Officer 255.8K 195.9K 28.8K 4.1K 484.6K 40.42%
127 2011 Judith E. O’Grady Senior Vice President, Regulatory Affairs and Quality Systems, and Corporate Compliance Officer 269.2K 100.0K 30.8K 3.3K 403.4K 24.80%
128 2010 Stuart M. Essig Executive Chairman and Former Chief Executive Officer 698.5K 5.18M 300.0K 2.9K 6.19M 83.81%
129 2010 Stuart M. Essig Chairman of the Board of Directors (former Chief Executive Officer and former Executive Chairman of the Board) 698.5K 5.18M 300.0K 2.9K 6.19M 83.81%
130 2010 Stuart M. Essig Chief Executive Officer 698.5K 5.18M 300.0K 2.9K 6.19M 83.81%
131 2010 John B. Henneman, III Executive Vice President, Finance and Administration, and Chief Financial Officer 499.2K 3.00M 250.0K 2.9K 3.75M 79.96%
132 2010 John B. Henneman, III Corporate Vice President, Finance and Administration, and Chief Financial Officer (former Executive Vice President, Finance and Administration, and Chief Financial Officer) 499.2K 3.00M 250.0K 2.9K 3.75M 79.96%
133 2010 John B. Henneman, III Executive Vice President, Finance and Administration, and Chief Financial Officer 499.2K 3.00M 250.0K 2.9K 3.75M 79.96%
134 2010 Peter J. Arduini President and Chief Executive Officer 92.3K 500.0K 1.50M 2.09M 71.69%
135 2010 Peter J. Arduini President and Chief Executive Officer and Director 92.3K 500.0K 1.50M 2.09M 71.69%
136 2010 Peter Arduini President and Chief Operating Officer 92.3K 500.0K 1.50M 2.09M 71.69%
137 2010 Gerard S. Carlozzi Former Executive Vice President and Chief Operating Officer 499.2K 237.5K 250.0K 986.7K 24.07%
138 2010 Judith E. O’Grady Senior Vice President, Regulatory Affairs and Quality Systems, and Corporate Compliance Officer 248.7K 58.7K 63.8K 3.9K 375.0K 15.65%
139 2010 Judith E. O’Grady Senior Vice President, Regulatory Affairs and Quality Systems, and Corporate Compliance Officer 248.7K 58.7K 63.8K 3.9K 375.0K 15.65%
140 2010 Jerry E. Corbin Vice President, Corporate Controller and Principal Accounting Officer 245.6K 61.0K 63.8K 4.1K 374.5K 16.29%
141 2010 Jerry E. Corbin Vice President, Corporate Controller and Principal Accounting Officer 245.6K 61.0K 63.8K 4.1K 374.5K 16.29%
142 2009 Stuart M. Essig Chief Executive Officer 614.8K 4.20M 3.6K 4.81M 87.15%
143 2009 Stuart M. Essig Executive Chairman and Former Chief Executive Officer 614.8K 4.20M 3.6K 4.81M 87.15%
144 2009 Stuart M. Essig President and Chief Executive Officer 614.8K 4.81M 0.00%
145 2009 John B. Henneman, III Executive Vice President, Finance and Administration, and Chief Financial Officer 457.4K 417.5K 3.6K 878.6K 47.52%
146 2009 John B. Henneman, III Executive Vice President, Finance and Administration, and Chief Financial Officer 457.4K 417.5K 3.6K 878.6K 47.52%
147 2009 Gerard S. Carlozzi Former Executive Vice President and Chief Operating Officer 457.4K 180.0K 637.4K 28.24%
148 2009 Gerard S. Carlozzi Executive Vice President and Chief Operating Officer 457.4K 637.4K 0.00%
149 2009 Judith E. O’Grady Senior Vice President, Regulatory Affairs, Quality Assurance and Clinical Affairs, and Corporate Compliance Officer 244.4K 482.7K 0.00%
150 2009 Judith E. O’Grady Senior Vice President, Regulatory Affairs and Quality Systems, and Corporate Compliance Officer 244.4K 146.7K 88.0K 3.6K 482.7K 30.38%
151 2009 Judith E. O’Grady Senior Vice President, Regulatory Affairs and Quality Systems, and Corporate Compliance Officer 244.4K 146.7K 88.0K 3.6K 482.7K 30.38%
152 2009 Jerry E. Corbin Vice President, Corporate Controller and Principal Accounting Officer 231.0K 150.2K 91.5K 3.6K 476.3K 31.53%
153 2009 Jerry E. Corbin Vice President, Corporate Controller and Principal Accounting Officer 231.0K 150.2K 91.5K 3.6K 476.3K 31.53%
154 2009 Peter J. Arduini President and Chief Executive Officer
155 2009 Peter Arduini President and Chief Operating Officer
156 2008 Stuart M. Essig Chief Executive Officer 600.0K 21.54M 3.9K 24.50M 87.91%
157 2008 Stuart M. Essig President and Chief Executive Officer 600.0K 24.50M 0.00%
158 2008 John B. Henneman, III Executive Vice President, Finance and Administration, and Chief Financial Officer 444.8K 3.35M 3.9K 4.67M 71.74%
159 2008 Gerard S. Carlozzi Former Executive Vice President and Chief Operating Officer 444.8K 3.35M 3.79M 88.27%
160 2008 Gerard S. Carlozzi Executive Vice President and Chief Operating Officer 444.8K 3.79M 0.00%
161 2008 Judith E. O’Grady Senior Vice President, Regulatory Affairs, Quality Assurance and Clinical Affairs, and Corporate Compliance Officer 242.8K 346.7K 0.00%
162 2008 Judith E. O’Grady Senior Vice President, Regulatory Affairs and Quality Systems, and Corporate Compliance Officer 242.8K 100.0K 3.9K 346.7K 28.85%
163 2008 Jerry E. Corbin Vice President, Corporate Controller and Principal Accounting Officer 227.4K 100.0K 3.9K 331.3K 30.19%
164 2008 Jerry E. Corbin Vice President and Corporate Controller 227.4K 82.0K 3.9K 313.3K 26.19%
165 2008 Peter Arduini President and Chief Operating Officer
166 2007 Stuart M. Essig President and Chief Executive Officer 550.0K 4.47M 0.00%
167 2007 John B. Henneman, III Executive Vice President, Finance and Administration, and Chief Financial Officer 420.0K 791.9K 0.00%
168 2007 Gerard S. Carlozzi Executive Vice President and Chief Operating Officer 416.5K 784.5K 0.00%
169 2007 Judith E. O’Grady Senior Vice President, Regulatory, Quality Assurance and Clinical Affairs 234.1K 87.3K 69.6K 3.9K 550.0K 15.87%
170 2007 Judith E. O’Grady Senior Vice President, Regulatory Affairs, Quality Assurance and Clinical Affairs, and Corporate Compliance Officer 234.1K 473.1K 0.00%
171 2007 Maureen B. Bellantoni Former Executive Vice President and Chief Financial Officer 220.7K 349.2K 452.8K 0.00%
172 2007 Jerry E. Corbin Vice President, Corporate Controller and Principal Accounting Officer 207.1K 383.5K 0.00%
173 2007 Jerry E. Corbin Vice President and Corporate Controller 207.1K 48.4K 51.8K 3.9K 311.2K 15.55%
174 2006 Stuart M. Essig President and Chief Executive Officer 500.0K 500.0K 3.8K 3.53M 0.00%
175 2006 Stuart M. Essig President and Chief Executive Officer 500.0K 500.0K 3.8K 3.53M 0.00%
176 2006 Gerard S. Carlozzi Executive Vice President and Chief Operating Officer 400.0K 160.0K 1.17M 2.70M 43.26%
177 2006 Gerard S. Carlozzi Executive Vice President and Chief Operating Officer 400.0K 1.17M 160.0K 2.70M 43.26%
178 2006 John B. Henneman, III Executive Vice President, Finance and Administration, and Chief Financial Officer 420.0K 168.0K 1.17M 3.8K 2.55M 45.91%
179 2006 John B. Henneman, III Executive Vice President, Finance and Administration, and Chief Financial Officer 420.0K 1.17M 168.0K 3.8K 2.55M 45.91%
180 2006 David B. Holtz 250.0K 233.3K 350.8K 1.02M 22.96%
181 2006 Maureen B. Bellantoni Former Executive Vice President and Chief Financial Officer 293.1K 117.1K 120.0K 118.4K 648.6K 18.05%
182 2006 Maureen B. Bellantoni Former Executive Vice President and Chief Financial Officer 293.1K 120.0K 117.1K 118.4K 648.6K 18.05%
183 2006 Judith E. O’Grady Senior Vice President, Regulatory, Quality Assurance and Clinical Affairs 227.6K 3.0K 37.4K 41.1K 3.8K 480.7K 7.78%
184 2006 Judith E. O’Grady Senior Vice President, Regulatory Affairs, Quality Assurance and Clinical Affairs, and Corporate Compliance Officer 227.6K 37.4K 44.1K 3.8K 480.7K 7.78%
185 2006 Judith E. O’Grady Senior Vice President, Regulatory, Quality Assurance and Clinical Affairs 227.6K 37.4K 44.1K 3.8K 480.7K 7.78%
186 2006 Jerry E. Corbin Vice President and Corporate Controller 97.2K 6.3K 32.2K 1.8K 137.6K 4.59%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-05-05 DEFA14A
2026-04-06 DEF 14A
2025-04-04 DEF 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-05 DEFA14A
2026-05-05 8-K
2026-05-05 8-K
2026-05-05 10-Q
2026-04-15 8-K
2026-04-06 DEF 14A
2026-03-27 SC 13G/A
2026-03-12 4
2026-03-12 4
2026-03-12 4

Executive team

NameTitleCompensationGender
Mojdeh Poul President, Chief Executive Officer & Director 2M female
Michael J. McBreen Executive Vice President & President of Codman Specialty Surgical 942.9K male
Lea Daniels Knight Executive Vice President & Chief Financial Officer 884.7K female
Robert T. Davis Jr. Executive Vice President & President of Tissue Technologies 722.4K male
Harvinder Singh Executive Vice President & President of International Business 714.6K male
Michael D. Hutchinson Executive Vice President, Chief Legal Officer & Secretary 549.5K male
Jeffrey Mosebrook Senior Vice President of Finance & Principal Accounting Officer 493.1K male
Teshtar Elavia Corporate VP & Chief Technology Officer male
Laurene Isip Vice President of Global Corporate Communications & Public Relations
Christopher Ward Senior Director of Investor Relations
ESG Rating
C+
MEDICAL - DEVICES
2019
E (Environmental)
63.6 / 62.5
Company / Sector avg.
S (Social)
62.8 / 68.9
Company / Sector avg.
G (Governance)
64.3 / 64.8
Company / Sector avg.
ESG Total
63.6 / 65.4
Company / Sector avg.
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
Transaction Date Disclosed Senator State Owner Type Amount Link
2015-02-13 2015-02-26 Thom Tillis NC Joint Sale (Full) $1,001 - $15,000
House Trading Activity
Transaction Date Disclosed Representative District Owner Type Amount Link
2024-06-18 2024-07-09 Josh Gottheimer NJ05 Joint Sale $1,001 - $15,000
2024-04-05 2024-05-15 Josh Gottheimer NJ05 Joint Sale (Partial) $1,001 - $15,000
2023-10-16 2023-11-11 Josh Gottheimer NJ05 Joint Purchase $1,001 - $15,000
2023-09-15 2023-10-15 Josh Gottheimer NJ05 Joint Sale $1,001 - $15,000
2023-06-13 2023-07-11 Josh Gottheimer NJ05 Joint Sale (Partial) $1,001 - $15,000
2020-10-16 2020-11-05 Josh Gottheimer NJ05 Joint Purchase $1,001 - $15,000
2020-09-15 2020-10-13 Josh Gottheimer NJ05 Joint Sale (Partial) $1,001 - $15,000
2020-03-10 2020-04-16 Gilbert Cisneros CA31 -- Purchase $1,001 - $15,000
2020-02-10 2020-03-10 Gilbert Cisneros CA31 Purchase $1,001 - $15,000
2020-02-03 2020-03-16 Josh Gottheimer NJ05 Joint Purchase $1,001 - $15,000
2019-01-09 2020-04-27 Donna Shalala FL27 -- Sale (Full) $1,001 - $15,000
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits